CLDI

Calidi Biotherapeutics, Inc. (CLDI) Risks & Opportunities Analysis (2026)

Invetso Score: 6.7/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 6.1 (Moderate)

Negative interest coverage and modest leverage versus peers leave CLDI more exposed to refinancing or funding-cost pressure if sector conditions tighten, while better-capitalized peers retain more flexibility.

A very high debt-to-equity ratio relative to stronger balance-sheet peers can constrain strategic optionality, making CLDI more vulnerable if demand softens or capital markets become less receptive.

The extremely extended cash-conversion cycle suggests working-capital dependence on supplier financing, which can amplify liquidity stress versus peers with faster cash generation.

If industry demand weakens, CLDI’s weaker earnings coverage could translate into faster margin compression than peers with stronger operating buffers and lower fixed financial obligations.

Opportunities

Score:

A current ratio above 1.6 provides near-term liquidity headroom, positioning CLDI better than more stretched peers to absorb volatility and fund working-capital needs.

Low net debt relative to EBITDA versus more levered peers supports resilience, giving CLDI more room to navigate cyclical softness without immediate balance-sheet pressure.

The negative cash-conversion cycle indicates supplier-funded operations, which can preserve cash in the near term and support growth execution versus peers that must self-fund more inventory.

If operating performance stabilizes, CLDI’s liquidity profile could allow faster recovery in capital allocation than peers facing tighter covenant or refinancing constraints.

Overall Score

Score:

CLDI’s forward positioning is balanced by liquidity support and low net debt, but weak interest coverage and working-capital dependence create meaningful downside versus stronger peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Calidi Biotherapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →

Invetso is not affiliated with or regulated by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other financial regulatory authority. The analyses, scores and all the information provided by Invetso are strictly for informational purposes only and do not constitute financial advice, recommendations, or an offer to buy or sell any securities. Invetso is not a registered financial advisor, broker-dealer, or investment advisor, and it does not provide personalized investment, legal, or tax advice. The content provided on this website is not intended to serve as a substitute for professional advice. Users should conduct their own research and consult with a qualified financial advisor before making any investment decisions. All analysis, data, and information presented on this site are based on publicly available information and should be used at the user’s own risk. Invetso does not guarantee the accuracy, completeness, or timeliness of any information or data provided, nor does it endorse any specific securities, companies, or strategies. Any reliance you place on such information is strictly at your own risk. While we strive to provide accurate and up-to-date information, Invetso makes no warranties or representations regarding the completeness, accuracy, or reliability of any analyses or data on our platform, and any such information is subject to the terms and conditions of the Invetso Terms of Service. Our analyses are generated using AI technologies and AI-generated content may contain errors or inaccuracies. Use the information at your own risk. Our platform may contain links to third-party websites, for which we are not responsible for the content or accuracy of information. Invetso shall not be liable for any loss or damage arising from the use of our services. By using this website, you agree that Invetso is not responsible for any losses, damages, or financial outcomes that may result from your use of the information, tools, or resources provided. We recommend consulting with a licensed financial professional before making any investment decisions.

For more details, please refer to our Terms of Service and Privacy Policy.